Loading stock data…
AngioDynamics (ANGO)
$13.16-0.23 (-1.75%)
Market OpenUpdated 2:06 PM EDT
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
AngioDynamics, Inc. in the Healthcare sector is trading at $13.16 with a market capitalization of $501M. Wall Street consensus targets $18.00 (4 analysts), implying a +36.7% move over the next 12 months. The stock is currently near its 52-week high of $13.99, remaining 14.8% above its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +36.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $78.42M↓ | $79.43M↑ | $75.71M↓ | $80.16M↑ | $72.00M |
| Gross Profit | $41.48M↓ | $44.78M↑ | $41.86M↓ | $42.22M↑ | $38.86M |
| Operating Income | -$6.43M↓ | -$2.49M↑ | -$7.90M↓ | -$3.63M↑ | -$6.65M |
| Net Income | -$8.08M↓ | -$6.35M↑ | -$10.90M↓ | -$6.05M↓ | -$4.41M |
Peer Comparison
JNJUNHPFE
Fundamentals
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internation...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$500.79M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-18.11%
Volume
Today's trading volume
166,837
Recent News
Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
ANGO's NanoKnife growth, strong Med Tech momentum and solid Q3 results support holding the stock despite tariff and inflation pressures.
Wall Street Analysts See a 50.5% Upside in AngioDynamics (ANGO): Can the Stock Really Move This High?
The mean of analysts' price targets for AngioDynamics (ANGO) points to a 50.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
ANGO gains momentum as NanoKnife adoption, strong Med Tech growth and positive clinical trends support its long-term outlook.
Wall Street Analysts Think AngioDynamics (ANGO) Could Surge 64.23%: Read This Before Placing a Bet
The mean of analysts' price targets for AngioDynamics (ANGO) points to a 64.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Wall Street Analysts Believe AngioDynamics (ANGO) Could Rally 65.75%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 65.8% in AngioDynamics (ANGO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.